Scilex (SCLX) Competitors $0.56 0.00 (-0.83%) (As of 01:20 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SCLX vs. MKTW, AQST, CGC, TKNO, TNGX, AKBA, LRMR, VERV, KALV, and VALNShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include MarketWise (MKTW), Aquestive Therapeutics (AQST), Canopy Growth (CGC), Alpha Teknova (TKNO), Tango Therapeutics (TNGX), Akebia Therapeutics (AKBA), Larimar Therapeutics (LRMR), Verve Therapeutics (VERV), KalVista Pharmaceuticals (KALV), and Valneva (VALN). Scilex vs. MarketWise Aquestive Therapeutics Canopy Growth Alpha Teknova Tango Therapeutics Akebia Therapeutics Larimar Therapeutics Verve Therapeutics KalVista Pharmaceuticals Valneva MarketWise (NASDAQ:MKTW) and Scilex (NASDAQ:SCLX) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk. Does the media refer more to MKTW or SCLX? In the previous week, MarketWise had 1 more articles in the media than Scilex. MarketBeat recorded 1 mentions for MarketWise and 0 mentions for Scilex. Scilex's average media sentiment score of 0.80 beat MarketWise's score of 0.59 indicating that Scilex is being referred to more favorably in the news media. Company Overall Sentiment MarketWise Positive Scilex Positive Does the MarketBeat Community prefer MKTW or SCLX? MarketWise received 16 more outperform votes than Scilex when rated by MarketBeat users. However, 100.00% of users gave Scilex an outperform vote while only 65.00% of users gave MarketWise an outperform vote. CompanyUnderperformOutperformMarketWiseOutperform Votes2665.00% Underperform Votes1435.00% ScilexOutperform Votes10100.00% Underperform VotesNo Votes Do insiders & institutionals have more ownership in MKTW or SCLX? 23.0% of MarketWise shares are held by institutional investors. Comparatively, 69.7% of Scilex shares are held by institutional investors. 28.6% of MarketWise shares are held by insiders. Comparatively, 8.7% of Scilex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, MKTW or SCLX? MarketWise has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Scilex has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Which has better earnings and valuation, MKTW or SCLX? MarketWise has higher revenue and earnings than Scilex. Scilex is trading at a lower price-to-earnings ratio than MarketWise, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarketWise$448.18M0.39$1.78M$0.124.50Scilex$46.74M2.37-$114.33M-$1.43-0.40 Is MKTW or SCLX more profitable? MarketWise has a net margin of 1.20% compared to Scilex's net margin of -233.88%. Scilex's return on equity of 0.00% beat MarketWise's return on equity.Company Net Margins Return on Equity Return on Assets MarketWise1.20% -1.89% 1.50% Scilex -233.88%N/A -111.82% Do analysts prefer MKTW or SCLX? MarketWise presently has a consensus target price of $2.00, indicating a potential upside of 270.37%. Scilex has a consensus target price of $11.33, indicating a potential upside of 1,866.23%. Given Scilex's stronger consensus rating and higher possible upside, analysts clearly believe Scilex is more favorable than MarketWise.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MarketWise 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Scilex 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryMarketWise and Scilex tied by winning 9 of the 18 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.55M$2.95B$5.08B$8.80BDividend YieldN/A1.91%5.02%4.07%P/E Ratio-0.4017.5291.2813.60Price / Sales2.37280.411,226.2187.40Price / CashN/A169.3839.4536.27Price / Book-0.524.366.906.33Net Income-$114.33M-$41.63M$118.83M$225.93M7 Day Performance-15.24%-5.54%-1.92%-0.96%1 Month Performance-41.18%-7.28%-3.75%1.06%1 Year Performance-39.17%25.27%31.37%26.59% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex3.4335 of 5 stars$0.56-0.8%$11.33+1,924.2%-48.7%$107.38M$46.74M-0.3980Gap UpMKTWMarketWise3.4246 of 5 stars$0.55+1.1%$2.00+266.4%-82.6%$177.01M$448.18M4.50578AQSTAquestive Therapeutics2.282 of 5 stars$4.64-2.1%$9.80+111.2%+164.5%$423.08M$50.58M-10.52160Short Interest ↓Positive NewsCGCCanopy Growth1.4716 of 5 stars$3.92+4.3%$3.50-10.7%-36.3%$413.01M$220.27M-0.811,029TKNOAlpha Teknova0.7199 of 5 stars$7.59-1.9%$5.00-34.1%+279.4%$404.62M$36.68M0.00240TNGXTango Therapeutics2.492 of 5 stars$3.70-9.3%$13.14+255.2%-46.4%$397.45M$36.53M-3.1590AKBAAkebia Therapeutics3.9344 of 5 stars$1.82+1.7%$5.75+215.9%+75.5%$397.09M$194.62M-7.85167LRMRLarimar Therapeutics3.6906 of 5 stars$6.22+2.3%$20.43+228.4%+93.6%$396.90MN/A0.0030Analyst ForecastVERVVerve Therapeutics2.4428 of 5 stars$4.66+2.4%$25.75+452.6%-63.2%$394.52M$11.76M0.00110KALVKalVista Pharmaceuticals3.7203 of 5 stars$9.10+1.6%$26.00+185.7%+9.1%$393.30MN/A0.00150Insider TradeNews CoverageVALNValneva2.2966 of 5 stars$4.56-2.4%$18.50+305.7%-62.1%$370.50M$165.52M-33.54700Gap Down Related Companies and Tools Related Companies MKTW Alternatives AQST Alternatives CGC Alternatives TKNO Alternatives TNGX Alternatives AKBA Alternatives LRMR Alternatives VERV Alternatives KALV Alternatives VALN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
